Vaidya Sane Ayurved Laboratories Limited Financial Ratios
MADHAVBAUG · Healthcare · Current price ₹162.1
P/E ratio
19.0x
P/B ratio
1.9x
ROE
12.5%
ROCE
15.7%
Debt / Equity
0.04
Dividend yield
0.3%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 19.0x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 1.9x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 12.5% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 15.7% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.04 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Vaidya Sane Ayurved Laboratories Limited's latest numbers.
Vaidya Sane Ayurved Laboratories Limited profitability
Vaidya Sane Ayurved Laboratories Limited generates a return on equity of 12.5% and a return on capital employed of 15.7%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.04 and a P/E of 19.0x, Vaidya Sane Ayurved Laboratories Limited is conservatively financed. Our overall business-quality score for the company is 5.0 / 10.
Understand the ratios
More on Vaidya Sane Ayurved Laboratories Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.